Official registry condition

Septic Shock peptide trials

6 selected ClinicalTrials.gov records carrying the official condition label Septic Shock. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

6 selected records.

Connected peptides

3 profiles.

Registry update years

2016–2026 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases3

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses3

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 90 selected PubMed records and 15 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Septic Shock unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00628160

PeptideScanner retained ClinicalTrials.gov record NCT00628160 at 2026-11-15T21:47:40.408Z. Its registry update date was 2016-02-24, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
February 24, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01718613

PeptideScanner retained ClinicalTrials.gov record NCT01718613 at 2026-11-15T22:08:31.832Z. Its registry update date was 2018-05-18, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
May 18, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05506319

PeptideScanner retained ClinicalTrials.gov record NCT05506319 at 2026-11-15T22:08:31.832Z. Its registry update date was 2025-03-14, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
March 14, 2025
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →